Jennifer Reeves, APRN
Family · Panama City, FLNPI 1720700529
Payments from drug & device makers
Across 587 payments — averaging $35.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Argenx US, Inc.$5K
- Boston Scientific$3K
- AbbVie$1K
- Lilly USA, LLC$1K
- UCB, Inc.$798
- Pfizer$764
- plus $9K from 49 others
What the payments were for
- Consulting fees$2,47512%
- Travel & lodging$4,07120%
- Food & beverage$13,98568%
- Education$450%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VYVGART HYTRULO$4,094
- VERCISE$3,054
- KISUNLA$347
- Hizentra$234
- REXULTI$232
- VYVGART$230
- GOCOVRI$130
- Senza$128
- GENERAL DBS$127
- Leqembi$122
- NUEDEXTA$116
- QULIPTA$115
- UBRELVY$115
- NURTEC ODT$114
- Rystiggo$111
- QUVIVIQ$110
- Austedo XR$110
- Symbravo$107
How this compares
$20,576 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VumerityDiroximel Fumarate | 14 | $138,277 |
| GocovriAmantadine Hcl | 25 | $103,978 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 21 | $99,144 |
| Nurtec OdtRimegepant Sulfate | 47 | $73,205 |
| InbrijaLevodopa | 25 | $56,094 |
| Aimovig AutoinjectorErenumab-Aooe | 50 | $49,156 |
| RexultiBrexpiprazole | 25 | $37,140 |
| UbrelvyUbrogepant | 26 | $33,555 |
| QuliptaAtogepant | 27 | $33,246 |
| Emgality PenGalcanezumab-Gnlm | 33 | $29,558 |
| BelsomraSuvorexant | 39 | $22,343 |
| Gabapentin | 655 | $13,498 |
| RytaryCarbidopa/Levodopa | 13 | $12,165 |
| Lidocaine | 79 | $9,724 |
| MovantikNaloxegol Oxalate | 17 | $7,820 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerOctagam, Nurtec Odt | $764 | $172,34968 claims |
| BiogenVumerity | $238 | $138,27714 claims |
| MDD US Operations, LLCGocovri | $316 | $103,97825 claims |
| AbbVieUbrelvy, Qulipta | $1,126 | $66,80153 claims |
| Acorda Therapeutics, IncInbrija | $99 | $56,09425 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $601 | $37,14025 claims |
| MerckBelsomra | $39 | $22,34339 claims |
| Amneal Pharmaceuticals LLCRytary | $30 | $12,16513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.
Other family in Panama City
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.